TNDM - Tandem Diabetes Care, Inc.
NEXT EARNINGS:
May 6, 2026
EPS Est: $-0.43
|
Rev Est: $244.7M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$29.85
DETAILS
HIGH:
$56.00
LOW:
$21.00
MEDIAN:
$27.00
CONSENSUS:
$29.85
UPSIDE:
10.97%
Market Cap:
1.82B
Volume:
6,247,587
Avg Volume:
1,572,490
52 Week Range:
9.98-35.12
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.69
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
2,650
IPO Date:
2013-11-14
EPS (TTM):
-3.04
P/E Ratio:
-7.22
Revenue (TTM):
1.01B
Total Assets:
881.11M
Total Debt:
444.48M
Cash & Equiv:
90.63M
Rev Growth (5Y):
15.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-25.9%
ROCE:
-12.2%
Debt/Equity:
2.86
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $-0.01 | $-0.05 | +80.0% | $290.4M | $249.7M | +16.3% |
| 2025-11-06 | $-0.31 | $-0.31 | 0.0% | $249.3M | $276.9M | -10.0% |
| 2025-08-06 | $-0.48 | $-0.40 | -20.0% | $240.7M | $250.2M | -3.8% |
| 2025-04-30 | $-0.67 | $-0.60 | -11.7% | $234.4M | $220.2M | +6.5% |
| 2025-02-26 | $-0.44 | $-0.25 | -76.0% | $282.6M | $251.4M | +12.4% |
| 2024-11-06 | $-0.36 | $-0.43 | +16.3% | $363.3M | $251.5M | +44.5% |
| 2024-08-01 | $-0.47 | $-0.54 | +13.0% | $221.9M | $204.9M | +8.3% |
| 2024-05-02 | $-0.63 | $-0.80 | +21.3% | $191.7M | $174.0M | +10.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.01B | 940.20M | 747.72M | 801.22M | 702.80M | 498.83M | 362.31M | 183.87M | 107.60M | 84.25M | 72.85M | 49.72M |
| Net Income | (204.71M) | (96.03M) | (222.61M) | (94.59M) | 15.57M | (34.38M) | (24.75M) | (122.61M) | (73.03M) | (83.45M) | (72.42M) | (79.52M) |
| EPS | -3.04 | -1.47 | -3.43 | -1.47 | 0.25 | -0.56 | -0.42 | -2.55 | -12.86 | -27.30 | -25.04 | -34.17 |
| Total Assets | 881.11M | 967.66M | 952.66M | 1.05B | 905.14M | 716.41M | 326.11M | 206.29M | 95.35M | 112.39M | 125.12M | 106.46M |
| Total Debt | 444.48M | 473.56M | 415.67M | 419.88M | 314.67M | 228.32M | 20.38M | 0 | 76.54M | 78.96M | 29.67M | 29.44M |
| Cash & Equivalents | 90.63M | 69.23M | 58.87M | 172.52M | 71.18M | 94.61M | 51.17M | 41.83M | 13.70M | 44.68M | 43.09M | 31.18M |
| Operating Cash Flow | (9.72M) | 24.23M | (31.81M) | 50.46M | 111.36M | 24.67M | 41.91M | (8.32M) | (66.14M) | (61.17M) | (58.76M) | (61.38M) |
| Free Cash Flow | (29.67M) | 4.99M | (58.61M) | 16.37M | 87.85M | (7.62M) | 22.36M | (11.30M) | (71.85M) | (70.10M) | (64.60M) | (65.96M) |
| FCF per Share | -0.44 | 0.08 | -0.90 | 0.26 | 1.39 | -0.13 | 0.38 | -0.23 | -12.66 | -22.93 | -22.34 | -28.34 |
| Book Value | 155.17M | 263.10M | 313.63M | 439.95M | 433.11M | 366.31M | 194.98M | 131.28M | (29.15M) | (5.93M) | 63.47M | 54.57M |
| Cash & ST Investments | 292.67M | 438.33M | 467.91M | 616.90M | 623.81M | 484.94M | 176.46M | 129.03M | 14.18M | 53.54M | 71.11M | 67.28M |
| ROC Equity | -1.32 | -0.36 | -0.71 | -0.22 | 0.04 | -0.09 | -0.13 | -0.93 | N/A | N/A | -1.14 | -1.46 |